510(k) device
0.014 Willow Guidewire
Arbor Endovascular, LLC · Guide, Wire, Catheter, Neurovasculature (MOF, Class II) · First FDA decision Jul 17, 2025, newest Nov 26, 2025Acute ischemic strokeBrain aneurysm
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "0.014 Willow"
MAUDE reports
0
Brand "0.014 Willow", since 2015
PubMed studies
0
Mentioning "0.014 Willow"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing 0.014 Willow Guidewire
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- 0.014 Willow Guidewire510(k)
K253168 · Decided Nov 26, 2025 · 61 days after receipt
Device type: Guide, Wire, Catheter, Neurovasculature (MOF) · Cardiology
- 0.014 Willow Guidewire510(k)
K243756 · Decided Jul 17, 2025 · 223 days after receipt
Device type: Guide, Wire, Catheter, Neurovasculature (MOF) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "0.014 Willow", any status and sponsor, newest update first.
No registered device study names "0.014 Willow".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "0.014 Willow", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MOF
671 reports: 477 malfunction, 182 injury, 9 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "0.014 Willow"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MOF.
- ASAHI Neurovascular Guide Wire CHIKAI X 014 softAsahi Intecc Co., Ltd. · 510(k) 2019
- Aristotle 14 GuidewireScientia Vascular, Inc. · 510(k) 2026
- Aristotle 18 GuidewireScientia Vascular, Inc. · 510(k) 2023
- Traxcess 7 Mini GuidewireMicroVention, Inc. · 510(k) 2020
- ASAHI CHIKAI Neurovascular Guide Wire (Round Curve)Asahi Intecc Co., Ltd. · 510(k) 2016
- Aristotle 65 MacrowireScientia Vascular · 510(k) 2026
- 35 Helix GuidewirePiraeus Medical, Inc. · 510(k) 2026
- Willow 12 GuidewireArbor Endovascular, LLC · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.